A67.9
Pinta, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Pinta is a chronic bacterial skin infection caused by the bacterium Treponema pallidum pertenue. It primarily affects individuals living in tropical regions with limited access to healthcare. Pinta is characterized by skin lesions that may cause cosmetic changes but generally do not cause systemic illness. It is classified under ICD-10 code A67.9, indicating an unspecified form of this disease. Understanding the causes, symptoms, diagnosis, and treatment options can help in managing this condition effectively.
Causes & Symptoms
Clinical Causes: Exposure to contaminated skin lesions or objects contaminated with Treponema pallidum pertenue bacteria. Prolonged close contact with an infected person. Living in areas with poor sanitation and limited access to healthcare services. Transmission is primarily skin-to-skin contact, especially in crowded or communal settings.
Key Symptoms: Painless, well-defined skin lesions which may be flat, shiny, or slightly raised. Lesions commonly appear on hands, feet, limbs, and face. Lesions may develop a crust or scaly surface over time. Potential cosmetic changes due to scarring or depigmentation. Skin lesions can persist for months or years if untreated. In some cases, there may be mild itching or irritation, but pain is uncommon.
Diagnostic & Treatment
Diagnosis Path: The diagnosis of pinta involves a combination of clinical evaluation and laboratory testing. Healthcare providers may examine skin lesions and inquire about exposure history. Laboratory methods used for confirmation include serological tests like microscopy of skin scrapings, antigen detection, or antibody tests designed for treponemal infections. A detailed medical history, especially regarding travel to endemic regions, helps support the diagnosis.
Treatment Protocols: Effective treatment of pinta typically involves antibiotics, with penicillin being the most commonly used medication. The specifics of treatment depend on the extent of the infection and overall health of the patient. Early treatment can prevent long-term skin damage and may halt the progression of the disease. Follow-up care is essential to monitor treatment response and manage any potential side effects. Preventive measures include improving sanitation and reducing close contact with infected individuals.
Clinical Advice & FAQs
Billing Guidance
Is A67.9 a billable ICD-10 code?
Yes, A67.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A67.9?
Clinical documentation must specify the nature of Pinta, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
